BIOSIMILARS. PIONEERED BY SANDOZ. Trademark

Trademark Overview

On Tuesday, December 11, 2012, a trademark application was filed for BIOSIMILARS. PIONEERED BY SANDOZ. with the United States Patent and Trademark Office. The USPTO has given the BIOSIMILARS. PIONEERED BY SANDOZ. trademark a serial number of 85799392. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 15, 2016. This trademark is owned by Novartis AG. The BIOSIMILARS. PIONEERED BY SANDOZ. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
biosimilars. pioneered by sandoz.

General Information

Serial Number85799392
Word MarkBIOSIMILARS. PIONEERED BY SANDOZ.
Filing DateTuesday, December 11, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 15, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 14, 2013

Trademark Statements

Indication of Colors claimedThe color(s) blue, light blue, black, white and gray is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOSIMILARS"
Description of MarkThe mark consists of the words "BIOSIMILARS. PIONEERED BY SANDOZ." preceded by a representation of a drop of liquid in which a double helix appears. The text is black, the drop of liquid is blue with a light blue center and black and white highlights surrounded by a light blue and black outline and the double helix is gray.
Goods and ServicesMedical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Pseudo MarkBIO SIMILARS. PIONEERED BY SANDOZ.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 20, 2012
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, August 15, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 15, 2016ABANDONMENT - NO USE STATEMENT FILED
Saturday, January 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 22, 2016EXTENSION 5 GRANTED
Tuesday, January 5, 2016EXTENSION 5 FILED
Tuesday, January 5, 2016TEAS EXTENSION RECEIVED
Thursday, July 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 15, 2015EXTENSION 4 GRANTED
Thursday, July 2, 2015EXTENSION 4 FILED
Thursday, July 2, 2015TEAS EXTENSION RECEIVED
Wednesday, January 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 27, 2015EXTENSION 3 GRANTED
Thursday, January 8, 2015EXTENSION 3 FILED
Thursday, January 8, 2015TEAS EXTENSION RECEIVED
Wednesday, August 6, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 5, 2014EXTENSION 2 GRANTED
Tuesday, July 8, 2014EXTENSION 2 FILED
Tuesday, August 5, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 8, 2014TEAS EXTENSION RECEIVED
Tuesday, January 7, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 4, 2014EXTENSION 1 GRANTED
Saturday, January 4, 2014EXTENSION 1 FILED
Saturday, January 4, 2014TEAS EXTENSION RECEIVED
Tuesday, July 9, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 14, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 24, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 10, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 9, 2013ASSIGNED TO LIE
Tuesday, March 19, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 19, 2013EXAMINER'S AMENDMENT ENTERED
Tuesday, March 19, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 19, 2013EXAMINERS AMENDMENT E-MAILED
Tuesday, March 19, 2013EXAMINERS AMENDMENT -WRITTEN
Monday, March 11, 2013ASSIGNED TO EXAMINER
Friday, December 21, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Thursday, December 20, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 14, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

sandoz pioneered biosimilars research medical clinical trials scientific information field providing pharmaceuticals pharmaceutical